RENAISSANCE TECHNOLOGIES LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1037389 NEW YORK, NY

Back to TAK Full portfolio

Position in TAK

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$55,358,132

+$14,538,835 QoQ

Shares Held

2,989,100

+14.2% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,196,847,717 across 49 Drug Manufacturers - Specialty & Generic names. TAK ranks #6 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,787,019	$1,059,666,526
2	NBIX	Neurocrine Biosciences Inc	2,418,897	$318,665,490
3	ALKS	Alkermes plc.	6,160,428	$217,832,734
4	RDY	Dr Reddys Laboratories Ltd	7,859,728	$108,857,232
5	SUPN	Supernus Pharmaceuticals, Inc.	1,705,222	$88,142,925
6	TAK	Takeda Pharmaceutical Co Ltd This page	2,989,100	$55,358,132
7	COLL	Collegium Pharmaceutical, Inc	1,469,449	$48,594,678
8	HIMS	Hims & Hers Health, Inc.	2,118,080	$43,971,340

All Filings in TAK

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$55,358,132	2,989,100	+14.2%	Shares	Sole	2026-05-14
2025-12-31	$40,819,297	2,618,300	-32.2%	Shares	Sole	2026-02-12
2025-09-30	$56,577,744	3,864,600	+17.1%	Shares	Sole	2025-11-13
2025-06-30	$51,005,632	3,299,200	+4.5%	Shares	Sole	2025-08-13
2025-03-31	$46,954,999	3,157,700	+2.5%	Shares	Sole	2025-05-14
2024-12-31	$40,771,256	3,079,400	-4.3%	Shares	Sole	2025-02-13
2024-09-30	$45,771,336	3,218,800	+8.9%	Shares	Sole	2024-11-13
2024-06-30	$38,235,112	2,954,800	-5.2%	Shares	Sole	2024-08-09
2024-03-31	$43,311,798	3,118,200	-6.3%	Shares	Sole	2024-05-13
2023-12-31	$47,481,998	3,327,400	+3.0%	Shares	Sole	2024-02-13
2023-09-30	$49,982,023	3,230,900	-11.5%	Shares	Sole	2023-11-14
2023-06-30	$57,341,500	3,650,000	+22.8%	Shares	Sole	2023-08-11
2023-03-31	$49,001,632	2,973,400	+3.8%	Shares	Sole	2023-05-12
2022-12-31	$44,684,640	2,864,400	+0.5%	Shares	Sole	2023-02-13
2022-09-30	$36,952,827	2,849,100	+0.7%	Shares	Sole	2022-11-14
2022-06-30	$39,709,332	2,828,300	+41.9%	Shares	Sole	2022-08-12
2022-03-31	$28,542,624	1,993,200	+16.0%	Shares	Sole	2022-05-13
2021-12-31	$23,427,244	1,718,800	-20.3%	Shares	Sole	2022-02-11
2021-09-30	$35,330,022	2,156,900	-6.1%	Shares	Sole	2021-11-12
2021-06-30	$38,658,510	2,297,000	-33.1%	Shares	Sole	2021-08-13
2021-03-31	$62,715,796	3,434,600	-38.4%	Shares	Sole	2021-05-13
2020-12-31	$101,532,340	5,578,700	-2.8%	Shares	Sole	2021-02-10
2020-09-30	$102,342,852	5,736,707	+2.3%	Shares	Sole	2020-11-13
2020-06-30	$100,546,061	5,607,700	+49.0%	Shares	Sole	2020-08-13
2020-03-31	$57,128,412	3,763,400	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.